Nathan Rich
Stock Analyst at Goldman Sachs
(0.79)
# 4,118
Out of 5,238 analysts
85
Total ratings
34.92%
Success rate
-10.51%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Sell | $215 → $158 | $274.96 | -42.54% | 8 | Feb 17, 2026 | |
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $21.31 | -1.45% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $82.83 | +136.63% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $11.00 | +172.73% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $13.20 | -39.39% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $24.24 | -27.81% | 4 | May 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $23.65 | -40.80% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $35.73 | -69.21% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $168.78 | +33.31% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $560.11 | +16.05% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $90.55 | -2.82% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $17.93 | -33.07% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $70.80 | +20.06% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $17.17 | -35.93% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $185.94 | +80.17% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $379.98 | +40.80% | 5 | Dec 14, 2021 |
Humana
Feb 17, 2026
Maintains: Sell
Price Target: $215 → $158
Current: $274.96
Upside: -42.54%
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $21.31
Upside: -1.45%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $82.83
Upside: +136.63%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $11.00
Upside: +172.73%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $13.20
Upside: -39.39%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $24.24
Upside: -27.81%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $23.65
Upside: -40.80%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $35.73
Upside: -69.21%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $168.78
Upside: +33.31%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $560.11
Upside: +16.05%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $90.55
Upside: -2.82%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $17.93
Upside: -33.07%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $70.80
Upside: +20.06%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $17.17
Upside: -35.93%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $185.94
Upside: +80.17%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $379.98
Upside: +40.80%